|
Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1034
|
$958B |
15.4x |
34.4x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$205
|
$522B |
5.6x |
14.7x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$224
|
$460B |
7.6x |
17.9x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 315
|
$339B |
4.4x |
11.1x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£138
|
$307B |
5.3x |
15.3x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 107
|
$279B |
5.0x |
12.3x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$101
|
$274B |
4.2x |
9.4x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$338
|
$227B |
6.3x |
12.7x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 307
|
$223B |
4.7x |
9.6x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$189B |
3.0x |
7.6x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$173B |
5.9x |
11.1x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$138B |
2.9x |
7.8x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€86
|
$130B |
2.5x |
8.3x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£18
|
$116B |
2.7x |
8.0x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$433
|
$105B |
8.8x |
20.8x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 8213
|
$81.1B |
10.2x |
20.0x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€34
|
$76.9B |
1.4x |
6.9x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$724
|
$70.3B |
4.9x |
13.9x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4454
|
$70.2B |
2.4x |
9.1x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€117
|
$69.7B |
2.8x |
9.9x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$124
|
$60.0B |
6.4x |
14.6x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$465
|
$60.0B |
16.6x |
91.1x |
|
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$53.7B |
3.7x |
14.6x |
|
argenx
|
Belgium |
Drug Development & Therapeutics
|
€781
|
$52.0B |
12.7x |
47.5x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 61
|
$51.7B |
11.1x |
37.2x |
|
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 163
|
$50.1B |
9.7x |
42.3x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 89
|
$46.3B |
2.7x |
9.1x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1807
|
$45.5B |
7.3x |
25.7x |
|
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€47
|
$43.5B |
1.7x |
9.9x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$207
|
$43.0B |
86.2x |
-38.1x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3561
|
$39.8B |
3.1x |
14.8x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 57
|
$35.0B |
3.2x |
14.7x |
|
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 205
|
$34.9B |
6.8x |
76.9x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$181
|
$29.1B |
3.0x |
9.5x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 9044
|
$28.7B |
1.9x |
7.7x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 40
|
$26.9B |
13.1x |
34.2x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$26.0B |
1.8x |
6.3x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1984
|
$25.7B |
2.0x |
8.6x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$22.3B |
2.2x |
6.3x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 362
|
$20.8B |
58.7x |
38.8x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 92
|
$19.3B |
10.5x |
77.8x |
|
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6455
|
$18.7B |
16.4x |
50.5x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$481
|
$17.6B |
5.5x |
10.6x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$17.0B |
3.5x |
11.5x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€9
|
$16.9B |
1.9x |
8.0x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2034
|
$16.2B |
4.5x |
11.8x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$74
|
$15.5B |
32.7x |
-33.3x |
|
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 171
|
$14.6B |
9.9x |
30.4x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$14.5B |
3.1x |
16.4x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$152
|
$14.5B |
5.1x |
21.8x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$14.4B |
3.1x |
11.6x |
|
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3721
|
$14.2B |
10.2x |
31.0x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€50
|
$14.1B |
4.7x |
12.5x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 338
|
$13.7B |
4.6x |
11.9x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 118
|
$13.6B |
29.6x |
-1038.1x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$167
|
$13.5B |
3.2x |
13.9x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$13.4B |
N/A |
-13.9x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$78
|
$13.2B |
4105.4x |
-12.1x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 25
|
$12.9B |
2.2x |
12.5x |
|
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€174
|
$12.7B |
N/A |
N/A |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1508
|
$12.4B |
3.9x |
16.1x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$81
|
$12.4B |
14.1x |
-33.2x |
|
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$580
|
$12.4B |
13.9x |
-40.9x |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 432
|
$12.3B |
44.9x |
-263.4x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.8B |
0.3x |
5.3x |
|
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1281
|
$11.7B |
3.1x |
12.6x |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€123
|
$11.2B |
2.6x |
6.8x |
|
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$10.8B |
4.7x |
11.7x |
|
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2630
|
$10.8B |
3.5x |
8.7x |
|
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 936
|
$10.7B |
3.9x |
13.9x |
|
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2206
|
$10.7B |
6.9x |
27.6x |
|
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2081
|
$10.5B |
3.8x |
14.9x |
|
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 43
|
$10.3B |
1.6x |
13.2x |
|
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$21
|
$10.1B |
514.1x |
-9.2x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$10.0B |
1.6x |
5.2x |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$10.0B |
2.5x |
10.1x |
|
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€60
|
$10.0B |
4.6x |
12.5x |
|
TransThera Sciences
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 193
|
$9.8B |
N/A |
N/A |
|
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$54
|
$9.6B |
3.0x |
12.5x |
|
Haisco Pharmaceutical
|
China |
Drug Development & Therapeutics
|
CNY 60
|
$9.6B |
15.2x |
82.6x |
|
Salubris Pharmaceuticals
|
China |
Drug Development & Therapeutics,
Medical Devices
|
CNY 60
|
$9.2B |
14.6x |
52.8x |
|
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€102
|
$9.2B |
952.6x |
-43.0x |
|
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$72
|
$9.0B |
502.9x |
-13.7x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$65
|
$8.4B |
6.4x |
9.8x |
|
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$84
|
$8.4B |
10.4x |
N/A |
|
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$8.3B |
11.0x |
119.0x |
|
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$8.1B |
103.7x |
-13.7x |
|
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4683
|
$8.1B |
1.6x |
12.6x |
|
Caliway Biopharmaceuticals
|
Taiwan |
Drug Development & Therapeutics
|
TWD 167
|
$8.0B |
7649.2x |
-240.8x |
|
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 42
|
$7.9B |
N/A |
N/A |
|
Sumitomo Pharma
|
Japan |
Drug Development & Therapeutics
|
JPY 2557
|
$7.9B |
2.9x |
11.7x |
|
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1209
|
$7.7B |
2.1x |
10.2x |
|
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$107
|
$7.4B |
N/A |
-18.4x |
|
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$148
|
$7.3B |
12.0x |
-43.6x |
|
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5648
|
$7.2B |
4.6x |
23.1x |
|
Kelun
|
China |
Drug Development & Therapeutics,
Medical Supplies
|
CNY 34
|
$7.2B |
2.7x |
13.7x |
|
Kyowa Kirin Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2571
|
$7.1B |
2.3x |
10.2x |
|
SK Biopharmaceuticals
|
South Korea |
Drug Development & Therapeutics
|
KRW 135500
|
$7.1B |
14.9x |
49.8x |
|
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$105
|
$6.7B |
36.6x |
-34.3x |
|
Merus
|
United States of America |
Drug Development & Therapeutics
|
$96
|
$6.7B |
127.3x |
-19.4x |